Bactericidal Effects
Bactericidal Effects - Related Videos
05:40
A Serum Bactericidal Assay for the Complement-Mediated Bactericidal Activity of Antibodies
0 Views •
2025
This video demonstrates a technique to evaluate the complement-mediated bactericidal activity of antibodies present in serum. This approach combines isolated serum with pathogenic bacteria and exogenous complement proteins. Upon incubation, the bacteria are grown on an agar plate, and the produced colonies are quantified to measure the serum bactericidal titer.
02:55
Determining the Role of Vitronectin in Bacterial Resistance to Bactericidal Activity of Human Serum
0 Views •
2025
This video demonstrates the role of vitronectin, a human serum glycoprotein, on bacterial resistance. Antibodies in the serum interact with bacterial surface proteins, activating complement proteins and forming the membrane attack complex, causing bacterial cell lysis. Vitronectin binding on bacterial membrane protein prevents the membrane attack complex formation, resulting in bacterial survival.
07:28
Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
0 Views •
Cited by 4 •
2020
The elucidation of the mode-of-action of a novel antibiotic is a challenging task in the drug discovery process. The goal of the method described here is the application of isothermal microcalorimetry using calScreener in antibacterial profiling to provide additional insight into drug-microbe interactions.
06:11
A High-throughput Shigella-specific Bactericidal Assay
0 Views •
Cited by 6 •
2019
Here we present a protocol to measure Shigellacidal activity of antibodies in serum. Serum is mixed with bacteria and exogenous complement, incubated, and the reaction mixture is plated on agar plates. Viable bacteria form colonies which are counted, using an automated colony enumerator, and used to determine the bactericidal titer.
02:19
Buffer Effectiveness
0 Views •
2020
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised. The buffer capacity is the amount of acid or base that can be added to a given volume...
FAQs
Bactericidal action can result from damage at several cellular levels. An antimicrobial agent or engineered material may compromise the bacterial cell membrane, damage the cell wall, interrupt essential metabolic processes, or cause irreversible genetic damage. These mechanisms provide different design routes for antimicrobial coatings, wound dressings, medical devices, and engineered surfaces intended to reduce bacterial contamination.
The cellular target helps explain how an agent or material produces bacterial killing. Membrane and cell-wall damage affect structural integrity, whereas metabolic interference disrupts essential functions and genetic damage affects cellular information. Connecting the target with a measured reduction in viable bacteria gives researchers a clearer basis for comparing antimicrobial materials and interpreting their performance.
Using distinct cellular damage pathways broadens the options available for controlling bacteria. A design may focus on membrane disruption, cell-wall damage, metabolic interference, or irreversible genetic injury, depending on the intended application. This mechanistic range supports development of antimicrobial surfaces and biomedical materials that address bacterial contamination through more than one biological vulnerability.
Assessment centers on measuring reductions in viable bacterial populations under defined conditions. Researchers can use this approach to determine whether a candidate agent, coating, dressing, device, or engineered surface decreases the population of living bacteria rather than only limiting growth. Controlled conditions make the resulting measurements more interpretable when antimicrobial strategies are compared.
These effects are especially relevant when bacterial contamination could compromise a biomedical material or engineered surface. Antimicrobial coatings, wound dressings, medical devices, and other designed interfaces can be developed to reduce bacterial contamination and infection risk. Evaluating viable-population reductions helps determine whether a candidate design provides the intended level of bacterial control.
A successful bioengineering strategy must combine bacterial control with biocompatibility. Researchers therefore seek antimicrobial agents and materials that reduce viable bacteria while remaining suitable for their intended biomedical context. This balance guides the development of coatings, dressings, devices, and surfaces that are not evaluated solely by killing activity, but also by their suitability for practical use.